Back
Bruker Corp. 10K Form
Sell
27
BRKR
Bruker Corp.
Last Price:
$38.28
Seasonality Move:
7.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2024-02-29 | 10K | BRKR/Bruker Corp. Annual |
| 2023-11-09 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-08-09 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-05-10 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-03-01 | 10K | BRKR/Bruker Corp. Annual |
Receive BRKR News And Ratings
See the #1 stock for the next 7 days that we like better than BRKR
BRKR Financial Statistics
Sales & Book Value
| Annual Sales: | $3.4B |
|---|---|
| Cash Flow: | $207.2M |
| Price / Cash Flow: | 134.36 |
| Annual Sales: | $16.06 |
| Price / Book: | 2.39 |
Profitability
| EPS (TTM): | -0.14870 |
|---|---|
| Net Income (TTM): | $-8.3M |
| Gross Margin: | $1.6B |
| Return on Equity: | -0.39% |
| Return on Assets: | -0.14% |
Bruker Corp. Earnings Forecast
Key Bruker Corp. Financial Ratios
-
The Gross Profit Margin over the past 27 years for BRKR is 45.61%.
-
The Selling, General & Administrative Expenses for BRKR have been equal to 27.54% of Gross Profit Margin.
-
The Research & Development expenses have been 11.50% of Revenue.
-
The Net Earning history of BRKR is -0.24% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 15 years.
Bruker Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BRKR |
| CUSIP: | 116794 |
| Website: | bruker.com |
Debt
| Debt-to-Equity Ratio: | 0.76 |
|---|---|
| Current Ratio: | 1.73 |
| Quick Ratio: | 0.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 49.58 |
|---|---|
| Forward P/E Ratio: | 15.83 |
BRKR Technical Analysis vs Fundamental Analysis
Sell
27
Bruker Corp. (BRKR)
is a Sell
Is Bruker Corp. a Buy or a Sell?
-
Bruker Corp. stock is rated a SellThe current Bruker Corp. [BRKR] share price is $38.28. The Score for BRKR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.